Drucker commented: GLP1 [drugs] have given us so many wonderful results, but tackling these very challenging brain disorders has been disappointing There was a hope that we would see some benefit, and we didnt. From the Alzheimers Drug Discovery Foundation (ADDF), Howard Fillit, MD, emphasized that even negative trials move the field forward, pointing to the need to target the broader pathobiology of Alzheimers and to consider preventive or combination approaches informed by biomarker profiles
Reas, D
Shao H, Yang S, Fonseca V, Stoecker C, Shi L
Week 2 As semaglutide builds up in your system, the appetite effects often become more consistent : Snacking may decrease, especially mindless or boredom eating Cravings may feel less intense or less frequent Meals may keep you satisfied for longer than they used to By week 2, some people see early weight changes on the scale, often in the range of 13 pounds , depending on starting weight and lifestyle habits